Year |
Citation |
Score |
2020 |
Biswas TK, VanderLaan PA, Que X, Gonen A, Krishack P, Binder CJ, Witztum JL, Getz GS, Reardon CA. CD1d Selectively Down Regulates the Expression of the Oxidized Phospholipid-Specific E06 IgM Natural Antibody in Mice. Antibodies (Basel, Switzerland). 9. PMID 32635160 DOI: 10.3390/Antib9030030 |
0.574 |
|
2019 |
Rodriguez A, Trigatti BL, Mineo C, Knaack D, Wilkins JT, Sahoo D, Asztalos BF, Mora S, Cuchel M, Pownall HJ, Rosales C, Bernatchez P, Ribeiro Martins da Silva A, Getz GS, Barber JL, et al. Proceedings of the Ninth HDL (High-Density Lipoprotein) Workshop: Focus on Cardiovascular Disease. Arteriosclerosis, Thrombosis, and Vascular Biology. ATVBAHA119313340. PMID 31597448 DOI: 10.1161/Atvbaha.119.313340 |
0.34 |
|
2019 |
VanderLaan PA, Reardon CA, Cabana VG, Wang CR, Getz GS. Invariant Natural Killer T-Cells and Total CD1d Restricted Cells Differentially Influence Lipid Metabolism and Atherosclerosis in Low Density Receptor Deficient Mice. International Journal of Molecular Sciences. 20. PMID 31540125 DOI: 10.3390/Ijms20184566 |
0.613 |
|
2019 |
Getz GS, Reardon CA. Apoproteins E, A-I, and SAA in Macrophage Pathobiology Related to Atherogenesis. Frontiers in Pharmacology. 10: 536. PMID 31231209 DOI: 10.3389/Fphar.2019.00536 |
0.377 |
|
2018 |
Getz GS, Reardon CA. Apoprotein E and Reverse Cholesterol Transport. International Journal of Molecular Sciences. 19. PMID 30404132 DOI: 10.3390/Ijms19113479 |
0.409 |
|
2018 |
Subramanian S, Goodspeed L, Wang S, Ding Y, O'Brien KD, Getz GS, Chait A, Reardon CA. Deficiency of Invariant Natural Killer T Cells Does Not Protect Against Obesity but Exacerbates Atherosclerosis in Ldlr-/- Mice. International Journal of Molecular Sciences. 19. PMID 29419749 DOI: 10.3390/Ijms19020510 |
0.325 |
|
2017 |
Pamir N, Hutchins PM, Ronsein GE, Wei H, Tang C, Das R, Vaisar T, Plow E, Schuster V, Reardon CA, Weinberg R, Dichek DA, Marcovina S, Getz GS, Heinecke JW. Plasminogen promotes cholesterol efflux by the ABCA1 pathway. Jci Insight. 2. PMID 28768900 DOI: 10.1172/Jci.Insight.92176 |
0.4 |
|
2017 |
Getz GS, Reardon CA. Genetic control of apoprotein A-I and atheroprotection: some insights from inbred strains of mice. Current Opinion in Lipidology. PMID 28731861 DOI: 10.1097/Mol.0000000000000442 |
0.32 |
|
2017 |
Getz GS, Reardon CA. Natural killer T cells in atherosclerosis. Nature Reviews. Cardiology. PMID 28127028 DOI: 10.1038/Nrcardio.2017.2 |
0.329 |
|
2016 |
Getz GS, Krishack PA, Reardon CA. Serum amyloid A and atherosclerosis. Current Opinion in Lipidology. 27: 531-5. PMID 27579547 DOI: 10.1097/Mol.0000000000000331 |
0.308 |
|
2016 |
Getz GS, Reardon CA. Do the Apoe-/- and Ldlr-/- Mice Yield the Same Insight on Atherogenesis? Arteriosclerosis, Thrombosis, and Vascular Biology. PMID 27386935 DOI: 10.1161/Atvbaha.116.306874 |
0.303 |
|
2016 |
Krishack PA, Sontag TJ, Getz GS, Reardon CA. Serum Amyloid A Regulates Monopoiesis in Hyperlipidemic Ldlr(-/-) Mice. Febs Letters. PMID 27339627 DOI: 10.1002/1873-3468.12269 |
0.303 |
|
2016 |
Chellan B, Reardon CA, Getz GS, Hofmann Bowman MA. Enzymatically Modified Low-Density Lipoprotein Promotes Foam Cell Formation in Smooth Muscle Cells via Macropinocytosis and Enhances Receptor-Mediated Uptake of Oxidized Low-Density Lipoprotein. Arteriosclerosis, Thrombosis, and Vascular Biology. 36: 1101-13. PMID 27079883 DOI: 10.1161/Atvbaha.116.307306 |
0.329 |
|
2016 |
Getz GS, Reardon CA. ApoE knockout and knockin mice: the history of their contribution to the understanding of atherogenesis. Journal of Lipid Research. 57: 758-66. PMID 27015743 DOI: 10.1194/Jlr.R067249 |
0.345 |
|
2015 |
Pamir N, Hutchins P, Ronsein G, Vaisar T, Reardon CA, Getz GS, Lusis AJ, Heinecke JW. Proteomic analysis of HDL from inbred mice strains implicates APOE associated with HDL in reduced cholesterol efflux capacity via the ABCA1 pathway. Journal of Lipid Research. PMID 26673204 DOI: 10.1194/Jlr.M063701 |
0.424 |
|
2015 |
Getz GS, Reardon CA. Atherogenic lipids and macrophage subsets. Current Opinion in Lipidology. 26: 357-61. PMID 26218415 DOI: 10.1097/Mol.0000000000000217 |
0.305 |
|
2015 |
Krishack PA, Bhanvadia CV, Lukens J, Sontag TJ, De Beer MC, Getz GS, Reardon CA. Serum Amyloid A Facilitates Early Lesion Development in Ldlr-/- Mice. Journal of the American Heart Association. 4. PMID 26187995 DOI: 10.1161/Jaha.115.001858 |
0.305 |
|
2015 |
Sontag TJ, Chellan B, Bhanvadia CV, Getz GS, Reardon CA. Alginic acid cell entrapment: a novel method for measuring in vivo macrophage cholesterol homeostasis. Journal of Lipid Research. 56: 470-83. PMID 25465389 DOI: 10.1194/Jlr.D052985 |
0.413 |
|
2015 |
Huang ZH, Reardon CA, Getz GS, Maeda N, Mazzone T. Selective suppression of adipose tissue apoE expression impacts systemic metabolic phenotype and adipose tissue inflammation. Journal of Lipid Research. 56: 215-26. PMID 25421060 DOI: 10.1194/Jlr.M050567 |
0.308 |
|
2014 |
Getz GS, Reardon CA. The mutual interplay of lipid metabolism and the cells of the immune system in relation to atherosclerosis. Clinical Lipidology. 9: 657-671. PMID 25705263 DOI: 10.2217/Clp.14.50 |
0.342 |
|
2014 |
Averill MM, Kim EJ, Goodspeed L, Wang S, Subramanian S, Den Hartigh LJ, Tang C, Ding Y, Reardon CA, Getz GS, Chait A. The apolipoprotein-AI mimetic peptide L4F at a modest dose does not attenuate weight gain, inflammation, or atherosclerosis in LDLR-null mice. Plos One. 9: e109252. PMID 25286043 DOI: 10.1371/Journal.Pone.0109252 |
0.398 |
|
2014 |
Wool GD, Reardon CA, Getz GS. Mimetic peptides of human apoA-I helix 10 get together to lower lipids and ameliorate atherosclerosis: is the action in the gut? Journal of Lipid Research. 55: 1983-5. PMID 25085258 DOI: 10.1194/Jlr.E053538 |
0.692 |
|
2014 |
Getz GS, Reardon CA. Myeloperoxidase-mediated dysfunctional high-density lipoprotein. Arteriosclerosis, Thrombosis, and Vascular Biology. 34: 695-6. PMID 24665120 DOI: 10.1161/Atvbaha.114.303282 |
0.354 |
|
2014 |
Getz GS. PCSK9 in South African variants of familial hypercholesterolemia. Journal of the American College of Cardiology. 63: 2374-5. PMID 24632264 DOI: 10.1016/J.Jacc.2014.01.059 |
0.364 |
|
2014 |
Sontag TJ, Krishack PA, Lukens JR, Bhanvadia CV, Getz GS, Reardon CA. Apolipoprotein A-I protection against atherosclerosis is dependent on genetic background. Arteriosclerosis, Thrombosis, and Vascular Biology. 34: 262-9. PMID 24334873 DOI: 10.1161/Atvbaha.113.302831 |
0.318 |
|
2013 |
Subramanian S, Turner MS, Ding Y, Goodspeed L, Wang S, Buckner JH, O'Brien K, Getz GS, Reardon CA, Chait A. Increased levels of invariant natural killer T lymphocytes worsen metabolic abnormalities and atherosclerosis in obese mice. Journal of Lipid Research. 54: 2831-41. PMID 23922382 DOI: 10.1194/Jlr.M041020 |
0.315 |
|
2013 |
Sontag TJ, Chellan B, Getz GS, Reardon CA. Differing rates of cholesterol absorption among inbred mouse strains yield differing levels of HDL-cholesterol. Journal of Lipid Research. 54: 2515-24. PMID 23812556 DOI: 10.1194/Jlr.M040055 |
0.396 |
|
2013 |
Huang ZH, Reardon CA, Subbaiah PV, Getz GS, Mazzone T. ApoE derived from adipose tissue does not suppress atherosclerosis or correct hyperlipidemia in apoE knockout mice. Journal of Lipid Research. 54: 202-13. PMID 23071294 DOI: 10.1194/Jlr.M031906 |
0.362 |
|
2012 |
Szeto FL, Reardon CA, Yoon D, Wang Y, Wong KE, Chen Y, Kong J, Liu SQ, Thadhani R, Getz GS, Li YC. Vitamin D receptor signaling inhibits atherosclerosis in Mice Molecular Endocrinology. 26: 1091-1101. PMID 22638071 DOI: 10.1210/Me.2011-1329 |
0.308 |
|
2012 |
Sontag TJ, Carnemolla R, Vaisar T, Reardon CA, Getz GS. Naturally occurring variant of mouse apolipoprotein A-I alters the lipid and HDL association properties of the protein. Journal of Lipid Research. 53: 951-63. PMID 22402133 DOI: 10.1194/Jlr.M021154 |
0.788 |
|
2012 |
Getz GS, Reardon CA. Animal models of atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology. 32: 1104-15. PMID 22383700 DOI: 10.1161/Atvbaha.111.237693 |
0.306 |
|
2012 |
LaDu MJ, Munson GW, Jungbauer L, Getz GS, Reardon CA, Tai LM, Yu C. Preferential interactions between ApoE-containing lipoproteins and Aβ revealed by a detection method that combines size exclusion chromatography with non-reducing gel-shift. Biochimica Et Biophysica Acta. 1821: 295-302. PMID 22138302 DOI: 10.1016/J.Bbalip.2011.11.005 |
0.321 |
|
2011 |
Getz GS, Reardon CA. Atherosclerosis: beyond cholesterol. Current Opinion in Lipidology. 22: 507-8. PMID 22101562 DOI: 10.1097/Mol.0B013E32834D179E |
0.396 |
|
2011 |
Getz GS, Reardon CA. Apolipoprotein A-I and A-I mimetic peptides: a role in atherosclerosis. Journal of Inflammation Research. 4: 83-92. PMID 22096372 DOI: 10.2147/Jir.S12983 |
0.423 |
|
2011 |
Tsimikas S, Miyanohara A, Hartvigsen K, Merki E, Shaw PX, Chou MY, Pattison J, Torzewski M, Sollors J, Friedmann T, Lai NC, Hammond HK, Getz GS, Reardon CA, Li AC, et al. Human oxidation-specific antibodies reduce foam cell formation and atherosclerosis progression. Journal of the American College of Cardiology. 58: 1715-27. PMID 21982317 DOI: 10.1016/J.Jacc.2011.07.017 |
0.31 |
|
2011 |
Getz GS, Vanderlaan PA, Reardon CA. Natural killer T cells in lipoprotein metabolism and atherosclerosis. Thrombosis and Haemostasis. 106: 814-9. PMID 21946866 DOI: 10.1160/Th11-05-0336 |
0.56 |
|
2011 |
Getz GS, Reardon CA. Cubbing in proapolipoprotein maturation. Journal of Lipid Research. 52: 1861-4. PMID 21900175 DOI: 10.1194/Jlr.R020149 |
0.417 |
|
2011 |
Getz GS, Reardon CA. The ABC transporters and the thickening cholesterol plot. Current Opinion in Lipidology. 22: 72-3. PMID 21233623 DOI: 10.1097/Mol.0B013E328342B0Fc |
0.309 |
|
2011 |
Peng D, Hiipakka RA, Xie JT, Dai Q, Kokontis JM, Reardon CA, Getz GS, Liao S. A novel potent synthetic steroidal liver X receptor agonist lowers plasma cholesterol and triglycerides and reduces atherosclerosis in LDLR(-/-) mice. British Journal of Pharmacology. 162: 1792-804. PMID 21232031 DOI: 10.1111/J.1476-5381.2011.01202.X |
0.342 |
|
2011 |
Wool GD, Cabana VG, Lukens J, Shaw PX, Binder CJ, Witztum JL, Reardon CA, Getz GS. 4F Peptide reduces nascent atherosclerosis and induces natural antibody production in apolipoprotein E-null mice. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 25: 290-300. PMID 20876212 DOI: 10.1096/Fj.10-165670 |
0.662 |
|
2010 |
Getz GS, Wool GD, Reardon CA. HDL apolipoprotein-related peptides in the treatment of atherosclerosis and other inflammatory disorders. Current Pharmaceutical Design. 16: 3173-84. PMID 20687877 DOI: 10.2174/138161210793292492 |
0.685 |
|
2010 |
Getz GS, Reardon CA. High-density lipoprotein function in regulating insulin secretion: possible relevance to metabolic syndrome. Arteriosclerosis, Thrombosis, and Vascular Biology. 30: 1497-9. PMID 20631346 DOI: 10.1161/Atvbaha.110.210583 |
0.346 |
|
2010 |
Getz GS, Wool GD, Reardon CA. Biological properties of apolipoprotein a-I mimetic peptides. Current Atherosclerosis Reports. 12: 96-104. PMID 20425244 DOI: 10.1007/S11883-010-0097-4 |
0.675 |
|
2010 |
Peng D, Hiipakka RA, Xie JT, Reardon CA, Getz GS, Liao S. Differential effects of activation of liver X receptor on plasma lipid homeostasis in wild-type and lipoprotein clearance-deficient mice. Atherosclerosis. 208: 126-33. PMID 19632679 DOI: 10.1016/J.Atherosclerosis.2009.07.016 |
0.388 |
|
2009 |
Wool GD, Vaisar T, Reardon CA, Getz GS. An apoA-I mimetic peptide containing a proline residue has greater in vivo HDL binding and anti-inflammatory ability than the 4F peptide. Journal of Lipid Research. 50: 1889-900. PMID 19433476 DOI: 10.1194/Jlr.M900151-Jlr200 |
0.692 |
|
2009 |
Getz GS, Wool GD, Reardon CA. Apoprotein A-I mimetic peptides and their potential anti-atherogenic mechanisms of action. Current Opinion in Lipidology. 20: 171-5. PMID 19373084 DOI: 10.1097/Mol.0B013E32832Ac051 |
0.655 |
|
2009 |
Gräbner R, Lötzer K, Döpping S, Hildner M, Radke D, Beer M, Spanbroek R, Lippert B, Reardon CA, Getz GS, Fu YX, Hehlgans T, Mebius RE, van der Wall M, Kruspe D, et al. Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/- mice. The Journal of Experimental Medicine. 206: 233-48. PMID 19139167 DOI: 10.1084/Jem.20080752 |
0.307 |
|
2009 |
Getz GS, Reardon CA. Apoprotein E as a lipid transport and signaling protein in the blood, liver, and artery wall. Journal of Lipid Research. 50: S156-61. PMID 19018038 DOI: 10.1194/Jlr.R800058-Jlr200 |
0.401 |
|
2009 |
VanderLaan PA, Reardon CA, Thisted RA, Getz GS. VLDL best predicts aortic root atherosclerosis in LDL receptor deficient mice. Journal of Lipid Research. 50: 376-85. PMID 18957695 DOI: 10.1194/Jlr.M800284-Jlr200 |
0.626 |
|
2009 |
Peng D, Hiipakka RA, Reardon CA, Getz GS, Liao S. Differential anti-atherosclerotic effects in the innominate artery and aortic sinus by the liver X receptor agonist T0901317. Atherosclerosis. 203: 59-66. PMID 18639878 DOI: 10.1016/J.Atherosclerosis.2008.05.058 |
0.324 |
|
2008 |
Peng D, Hiipakka RA, Dai Q, Guo J, Reardon CA, Getz GS, Liao S. Antiatherosclerotic effects of a novel synthetic tissue-selective steroidal liver X receptor agonist in low-density lipoprotein receptor-deficient mice. The Journal of Pharmacology and Experimental Therapeutics. 327: 332-42. PMID 18723776 DOI: 10.1124/Jpet.108.142687 |
0.372 |
|
2008 |
Getz GS. The two Cs: ceramide and cardiomyopathy. Journal of Lipid Research. 49: 2077-8. PMID 18650556 DOI: 10.1194/Jlr.E800015-Jlr200 |
0.331 |
|
2008 |
Carnemolla R, Ren X, Biswas TK, Meredith SC, Reardon CA, Wang J, Getz GS. The specific amino acid sequence between helices 7 and 8 influences the binding specificity of human apolipoprotein A-I for high density lipoprotein (HDL) subclasses: a potential for HDL preferential generation. The Journal of Biological Chemistry. 283: 15779-88. PMID 18385132 DOI: 10.1074/Jbc.M710244200 |
0.784 |
|
2008 |
Getz GS. Murine atherosclerosis. Part III. Current Drug Targets. 9: 173. PMID 18336234 DOI: 10.2174/138945008783755548 |
0.362 |
|
2008 |
Wool GD, Reardon CA, Getz GS. Apolipoprotein A-I mimetic peptide helix number and helix linker influence potentially anti-atherogenic properties. Journal of Lipid Research. 49: 1268-83. PMID 18323574 DOI: 10.1194/Jlr.M700552-Jlr200 |
0.675 |
|
2008 |
Getz GS, Reardon CA. SAA, HDL biogenesis, and inflammation. Journal of Lipid Research. 49: 269-70. PMID 18199807 DOI: 10.1194/Jlr.E700012-Jlr200 |
0.359 |
|
2007 |
Getz GS, Vanderlaan PA, Reardon CA. The immune system and murine atherosclerosis. Current Drug Targets. 8: 1297-306. PMID 18220706 DOI: 10.2174/138945007783220669 |
0.535 |
|
2007 |
Lo JC, Wang Y, Tumanov AV, Bamji M, Yao Z, Reardon CA, Getz GS, Fu YX. Lymphotoxin beta receptor-dependent control of lipid homeostasis. Science (New York, N.Y.). 316: 285-8. PMID 17431181 DOI: 10.1126/Science.1137221 |
0.357 |
|
2007 |
VanderLaan PA, Reardon CA, Sagiv Y, Blachowicz L, Lukens J, Nissenbaum M, Wang CR, Getz GS. Characterization of the natural killer T-cell response in an adoptive transfer model of atherosclerosis. The American Journal of Pathology. 170: 1100-7. PMID 17322392 DOI: 10.2353/Ajpath.2007.060188 |
0.604 |
|
2006 |
LaDu MJ, Stine WB, Narita M, Getz GS, Reardon CA, Bu G. Self-assembly of HEK cell-secreted ApoE particles resembles ApoE enrichment of lipoproteins as a ligand for the LDL receptor-related protein. Biochemistry. 45: 381-90. PMID 16401069 DOI: 10.1021/Bi051765S |
0.344 |
|
2006 |
Getz GS, Reardon CA. Diet and murine atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology. 26: 242-9. PMID 16373607 DOI: 10.1161/01.Atv.0000201071.49029.17 |
0.403 |
|
2006 |
Reardon CA, Blachowicz L, Gupta G, Lukens J, Nissenbaum M, Getz GS. Site-specific influence of polyunsaturated fatty acids on atherosclerosis in immune incompetent LDL receptor deficient mice. Atherosclerosis. 187: 325-31. PMID 16280127 DOI: 10.1016/J.Atherosclerosis.2005.10.004 |
0.366 |
|
2005 |
Ren X, Zhao L, Sivashanmugam A, Miao Y, Korando L, Yang Z, Reardon CA, Getz GS, Brouillette CG, Jerome WG, Wang J. Engineering mouse apolipoprotein A-I into a monomeric, active protein useful for structural determination. Biochemistry. 44: 14907-19. PMID 16274238 DOI: 10.1021/Bi0508385 |
0.355 |
|
2004 |
Reardon CA, Miller ER, Blachowicz L, Lukens J, Binder CJ, Witztum JL, Getz GS. Autoantibodies to OxLDL fail to alter the clearance of injected OxLDL in apolipoprotein E-deficient mice. Journal of Lipid Research. 45: 1347-54. PMID 15102879 DOI: 10.1194/Jlr.M400075-Jlr200 |
0.346 |
|
2004 |
VanderLaan PA, Reardon CA, Getz GS. Site specificity of atherosclerosis: site-selective responses to atherosclerotic modulators. Arteriosclerosis, Thrombosis, and Vascular Biology. 24: 12-22. PMID 14604830 DOI: 10.1161/01.Atv.0000105054.43931.F0 |
0.545 |
|
2004 |
Cabana VG, Feng N, Reardon CA, Lukens J, Webb NR, de Beer FC, Getz GS. Influence of apoA-I and apoE on the formation of serum amyloid A-containing lipoproteins in vivo and in vitro. Journal of Lipid Research. 45: 317-25. PMID 14595002 DOI: 10.1194/Jlr.M300414-Jlr200 |
0.416 |
|
2003 |
Edelstein C, Pfaffinger D, Hinman J, Miller E, Lipkind G, Tsimikas S, Bergmark C, Getz GS, Witztum JL, Scanu AM. Lysine-phosphatidylcholine adducts in kringle V impart unique immunological and potential pro-inflammatory properties to human apolipoprotein(a). The Journal of Biological Chemistry. 278: 52841-7. PMID 14557258 DOI: 10.1074/Jbc.M310425200 |
0.339 |
|
2003 |
Peng D, Song C, Reardon CA, Liao S, Getz GS. Lipoproteins produced by ApoE-/- astrocytes infected with adenovirus expressing human ApoE. Journal of Neurochemistry. 86: 1391-402. PMID 12950448 DOI: 10.1046/J.1471-4159.2003.01950.X |
0.364 |
|
2003 |
Reardon CA, Blachowicz L, Lukens J, Nissenbaum M, Getz GS. Genetic background selectively influences innominate artery atherosclerosis: immune system deficiency as a probe. Arteriosclerosis, Thrombosis, and Vascular Biology. 23: 1449-54. PMID 12791670 DOI: 10.1161/01.Atv.0000079793.58054.2E |
0.314 |
|
2003 |
Cabana VG, Reardon CA, Feng N, Neath S, Lukens J, Getz GS. Serum paraoxonase: effect of the apolipoprotein composition of HDL and the acute phase response. Journal of Lipid Research. 44: 780-92. PMID 12562837 DOI: 10.1194/Jlr.M200432-Jlr200 |
0.412 |
|
2002 |
Getz GS. Do natural killer cells participate in a killer vascular disease? Arteriosclerosis, Thrombosis, and Vascular Biology. 22: 1251-3. PMID 12171782 DOI: 10.1161/01.Atv.0000027413.63734.42 |
0.316 |
|
2002 |
Reschly EJ, Sorci-Thomas MG, Davidson WS, Meredith SC, Reardon CA, Getz GS. Apolipoprotein A-I alpha -helices 7 and 8 modulate high density lipoprotein subclass distribution. The Journal of Biological Chemistry. 277: 9645-54. PMID 11744719 DOI: 10.1074/Jbc.M107883200 |
0.759 |
|
2001 |
Reardon CA, Kan HY, Cabana V, Blachowicz L, Lukens JR, Wu Q, Liadaki K, Getz GS, Zannis VI. In vivo studies of HDL assembly and metabolism using adenovirus-mediated transfer of apoA-I mutants in apoA-I-deficient mice Biochemistry. 40: 13670-13680. PMID 11695916 DOI: 10.1021/Bi011451E |
0.393 |
|
2001 |
Reardon CA, Blachowicz L, White T, Cabana V, Wang Y, Lukens J, Bluestone J, Getz GS. Effect of immune deficiency on lipoproteins and atherosclerosis in male apolipoprotein E-deficient mice. Arteriosclerosis, Thrombosis, and Vascular Biology. 21: 1011-6. PMID 11397712 DOI: 10.1161/01.Atv.21.6.1011 |
0.37 |
|
2001 |
Reardon CA, Getz GS. Mouse models of atherosclerosis. Current Opinion in Lipidology. 12: 167-73. PMID 11264988 DOI: 10.1097/00041433-200104000-00010 |
0.372 |
|
2001 |
Getz GS. The First Human Monoclonal Antibody to Oxidized LDL Arteriosclerosis, Thrombosis, and Vascular Biology. 21: 1254-1255. DOI: 10.1161/Atvb.21.8.1254 |
0.327 |
|
2000 |
Elhage R, Clamens S, Reardon-Alulis C, Getz GS, Fievet C, Maret A, Arnal JO, Bayard F. Loss of Atheroprotective Effect of Estradiol in Immunodeficient Mice. Endocrinology. 141: 462-465. PMID 28201069 DOI: 10.1210/Endo.141.1.7377 |
0.313 |
|
2000 |
LaDu MJ, Shah JA, Reardon CA, Getz GS, Bu G, Hu J, Guo L, van Eldik LJ. Apolipoprotein E receptors mediate the effects of beta-amyloid on astrocyte cultures. The Journal of Biological Chemistry. 275: 33974-80. PMID 10940295 DOI: 10.1074/Jbc.M000602200 |
0.301 |
|
2000 |
Ladu MJ, Reardon C, Van Eldik L, Fagan AM, Bu G, Holtzman D, Getz GS. Lipoproteins in the central nervous system. Annals of the New York Academy of Sciences. 903: 167-75. PMID 10818504 DOI: 10.1111/J.1749-6632.2000.Tb06365.X |
0.308 |
|
1999 |
Fagan AM, Holtzman DM, Munson G, Mathur T, Schneider D, Chang LK, Getz GS, Reardon CA, Lukens J, Shah JA, LaDu MJ. Unique lipoproteins secreted by primary astrocytes from wild type, apoE (-/-), and human apoE transgenic mice. The Journal of Biological Chemistry. 274: 30001-7. PMID 10514484 DOI: 10.1074/Jbc.274.42.30001 |
0.381 |
|
1998 |
Lewis GF, Uffelman KD, Lamarche B, Cabana VG, Getz GS. Production of small high-density lipoprotein particles after stimulation of in vivo lipolysis in hypertriglyceridemic individuals: Studies before and after triglyceride-lowering therapy Metabolism: Clinical and Experimental. 47: 234-242. PMID 9472977 DOI: 10.1016/S0026-0495(98)90227-X |
0.385 |
|
1997 |
Cabana VG, Gidding SS, Getz GS, Chapman J, Shulman ST. Serum amyloid A and high density lipoprotein participate in the acute phase response of Kawasaki disease. Pediatric Research. 42: 651-5. PMID 9357939 DOI: 10.1203/00006450-199711000-00017 |
0.376 |
|
1997 |
Cabana V, Reardon C, Getz G. 4.P.376 Production of serum amyloid A (SAA)-HDL does not require the presence of ApoA-I-HDL or matured T and B cells Atherosclerosis. 134: 376. DOI: 10.1016/S0021-9150(97)89906-6 |
0.327 |
|
1996 |
Thurberg BL, Reardon CA, Getz GS. Lipoprotein association of human apolipoprotein E/A-I chimeras. Expression in transfected hepatoma cells. The Journal of Biological Chemistry. 271: 6062-70. PMID 8626391 DOI: 10.1074/Jbc.271.11.6062 |
0.369 |
|
1995 |
Kushwaha RS, Barrett PHR, Reardon CA, Lewis DS, Carey KD, Getz GS, McGill HC. Relationships of plasma and hepatic variables with rates of plasma low-density lipoprotein apolipoprotein B metabolism in baboons fed low- and high-fat diets Metabolism. 44: 1058-1066. PMID 7637648 DOI: 10.1016/0026-0495(95)90105-1 |
0.381 |
|
1994 |
Kushwaha RS, Reardon CA, Lewis DS, Qi Y, Rice KS, Getz GS, Carey KD, McGill HC. Effect of dietary lipids on plasma activity and hepatic mRNA levels of cholesteryl ester transfer protein in high-and low-responding baboons (Papio species) Metabolism. 43: 1006-1012. PMID 8052139 DOI: 10.1016/0026-0495(94)90181-3 |
0.373 |
|
1992 |
O'Meara NM, Lewis GF, Cabana VG, Iverius PH, Getz GS, Polonsky KS. Role of basal triglyceride and high density lipoprotein in determination of postprandial lipid and lipoprotein responses. The Journal of Clinical Endocrinology and Metabolism. 75: 465-71. PMID 1639947 DOI: 10.1210/Jcem.75.2.1639947 |
0.379 |
|
1991 |
Getz GS. The involvement of lipoproteins in atherogenesis. Evolving concepts. Annals of the New York Academy of Sciences. 598: 17-28. PMID 2248436 DOI: 10.1111/J.1749-6632.1990.Tb42272.X |
0.33 |
|
1991 |
Lewis GF, O'Meara NM, Soltys PA, Blackman JD, Iverius PH, Pugh WL, Getz GS, Polonsky KS. Fasting hypertriglyceridemia in noninsulin-dependent diabetes mellitus is an important predictor of postprandial lipid and lipoprotein abnormalities. The Journal of Clinical Endocrinology and Metabolism. 72: 934-44. PMID 2005221 DOI: 10.1210/Jcem-72-4-934 |
0.323 |
|
1990 |
Lewis GF, O'Meara NM, Soltys PA, Blackman JD, Iverius PH, Druetzler AF, Getz GS, Polonsky KS. Postprandial lipoprotein metabolism in normal and obese subjects: comparison after the vitamin A fat-loading test. The Journal of Clinical Endocrinology and Metabolism. 71: 1041-50. PMID 2401706 DOI: 10.1210/Jcem-71-4-1041 |
0.325 |
|
1990 |
Driscoll DM, Mazzone T, Matsushima T, Getz GS. Apoprotein E biosynthesis in the cholesterol-fed guinea pig Arteriosclerosis, Thrombosis, and Vascular Biology. 10: 31-39. PMID 2297345 DOI: 10.1161/01.Atv.10.1.31 |
0.377 |
|
1990 |
LaRosa JC, Hunninghake D, Bush D, Criqui MH, Getz GS, Gotto AM, Grundy SM, Rakita L, Robertson RM, Weisfeldt ML. The cholesterol facts. A summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease. A joint statement by the American Heart Association and the National Heart, Lung, and Blood Institute. The Task Force on Cholesterol Issues, American Heart Association. Circulation. 81: 1721-33. PMID 2184951 DOI: 10.1161/01.Cir.81.5.1721 |
0.303 |
|
1990 |
Getz GS. An Overview of Atherosclerosis: A Look to the Future* Toxicologic Pathology. 18: 623-635. DOI: 10.1177/019262339001804A12 |
0.305 |
|
1989 |
Soltys PA, Mazzone T, Wissler RW, Vahed S, Rangnekar V, Lukens J, Vesselinovitch D, Getz GS. Effects of feeding fish oil on the properties of lipoproteins isolated from rhesus monkeys consuming an atherogenic diet. Atherosclerosis. 76: 103-15. PMID 2730707 DOI: 10.1016/0021-9150(89)90093-2 |
0.315 |
|
1987 |
Getz GS, Soltys PA, Carey KD, McGill HC, Hay R. Nutrition and biogenesis of plasma lipoproteins in nonhuman primates. American Heart Journal. 113: 440-5. PMID 3812203 DOI: 10.1016/0002-8703(87)90611-9 |
0.409 |
|
1986 |
Driscoll DM, Getz GS. Molecular and cell biology of lipoprotein biosynthesis Methods in Enzymology. 128: 41-70. PMID 3523142 DOI: 10.1016/0076-6879(86)28062-3 |
0.384 |
|
1985 |
Tonsgard JH, Getz GS. Effect of Reye's syndrome serum on isolated chinchilla liver mitochondria. The Journal of Clinical Investigation. 76: 816-25. PMID 4031073 DOI: 10.1172/Jci112039 |
0.303 |
|
1985 |
Goldberg RB, Rabin D, Alexander AN, Doelle GC, Getz GS. Suppression of plasma testosterone leads to an increase in serum total and high density lipoprotein cholesterol and apoproteins A-I and B. The Journal of Clinical Endocrinology and Metabolism. 60: 203-7. PMID 3917267 DOI: 10.1210/Jcem-60-1-203 |
0.366 |
|
1984 |
Bates SR, Murphy PL, Feng ZC, Kanazawa T, Getz GS. Very low density lipoproteins promote triglyceride accumulation in macrophages. Arteriosclerosis (Dallas, Tex.). 4: 103-14. PMID 6704048 DOI: 10.1161/01.Atv.4.2.103 |
0.388 |
|
1984 |
Goldberg RB, Fless GM, Baker SG, Joffe BI, Getz GS, Scanu AM, Seftel HC. Abnormalities of high density lipoproteins in homozygous familial hypercholesterolemia. Arteriosclerosis (Dallas, Tex.). 4: 472-8. PMID 6477298 DOI: 10.1161/01.Atv.4.5.472 |
0.369 |
|
1983 |
Feng ZC, Bates SR, Getz GS, Wissler RW. The receptor-mediated accumulation of triglyceride in macrophage exposed to very low density lipoproteins. Acta Academiae Medicinae Wuhan = Wu-Han I Hsã¼Eh Yã¼An Hsã¼Eh Pao. 3: 8-15. PMID 6866383 DOI: 10.1007/Bf02858434 |
0.347 |
|
1982 |
Borensztajn J, Getz GS, Padley RJ, Kotlar TJ. The apoprotein B-independent hepatic uptake of chylomicron remnants. The Biochemical Journal. 204: 609-12. PMID 7115352 DOI: 10.1042/Bj2040609 |
0.333 |
|
1981 |
Krishnaiah KV, Walker LF, Borensztajn J, Schonfeld G, Getz GS. Apolipoprotein B variant derived from rat intestine. Proceedings of the National Academy of Sciences of the United States of America. 77: 3806-10. PMID 6933436 DOI: 10.1073/Pnas.77.7.3806 |
0.371 |
|
1979 |
Lusk LT, Walker LF, DuBien LH, Getz GS. Isolation and partial characterization of high-density lipoprotein HDL1 from rat plasma by gradient centrifugation Biochemical Journal. 183: 83-90. PMID 230819 DOI: 10.1042/Bj1830083 |
0.391 |
|
1974 |
Vesselinovitch D, Getz GS, Hughes RH, Wissler RW. Atherosclerosis in the rhesus monkey fed three food fats Atherosclerosis. 20: 303-321. PMID 4369795 DOI: 10.1016/0021-9150(74)90015-X |
0.321 |
|
1973 |
Pottenger LA, Frazier LE, DuBien LH, Getz GS, Wissler RW. Carbohydrate composition of lipoprotein apoproteins isolated from rat plasma and from the livers of rats fed orotic acid Biochemical and Biophysical Research Communications. 54: 770-776. PMID 4356982 DOI: 10.1016/0006-291X(73)91490-3 |
0.369 |
|
1972 |
Borensztajn J, Getz GS. The contribution of lipogenesis in situ to the accumulation of fat by rat adipose tissue. Biochimica Et Biophysica Acta. 280: 86-93. PMID 5070660 DOI: 10.1016/0005-2760(72)90215-9 |
0.333 |
|
1971 |
Hay RV, Pottenger LA, Reingold AL, Getz GS, Wissler RW. Degradation of I125-labelled serum low density lipoprotein in normal and estrogen-treated male rats Biochemical and Biophysical Research Communications. 44: 1471-1477. PMID 5160706 DOI: 10.1016/S0006-291X(71)80251-6 |
0.374 |
|
1970 |
Getz GS. Lipids in membrane development. Advances in Lipid Research. 8: 175-223. DOI: 10.1016/B978-0-12-024908-4.50011-8 |
0.317 |
|
1969 |
McKay R, Druyan R, Getz GS, Rabinowitz M. Intramitochondrial localization of delta-aminolaevulate synthetase and ferrochelatase in rat liver. The Biochemical Journal. 114: 455-61. PMID 5820634 DOI: 10.1042/Bj1140455 |
0.304 |
|
1969 |
Getz GS, Vesselinovitch D, Wissler RW. A dynamic pathology of atherosclerosis The American Journal of Medicine. 46: 657-673. PMID 4892335 DOI: 10.1016/0002-9343(69)90018-7 |
0.315 |
|
1968 |
Getz GS, Bartley W, Lurie D, Notton BM. The phospholipids of various sheep organs, rat liver and of their subcellular fractions. Biochimica Et Biophysica Acta. 152: 325-39. PMID 5639262 DOI: 10.1016/0005-2760(68)90040-4 |
0.734 |
|
1962 |
Bartley W, Getz GS, Notton BM, Renshaw A. The lipid composition of phosphorylating ;digitonin particles' and water- and saline-extracted mitochondria from rat liver. The Biochemical Journal. 82: 540-53. PMID 16748944 DOI: 10.1042/Bj0820540 |
0.728 |
|
1962 |
GETZ GS, BARTLEY W, STIRPE F, NOTTON BM, RENSHAW A. The lipid composition of rat-liver mitochondria, fluffy layer and microsomes The Biochemical Journal. 83: 181-191. PMID 13898136 DOI: 10.1042/Bj0830181 |
0.733 |
|
1961 |
GETZ GS, BARTLEY W, STRIPE F, NOTTON BM, RENSHAW A, ROBINSON DS. The lipid composition of rat-liver cell sap The Biochemical Journal. 81: 214-220. PMID 13898137 |
0.73 |
|
1961 |
GETZ GS, BARTLEY W. The intracellular distribution of fatty acids in rat liver. The fatty acids of intracellular compartments. The Biochemical Journal. 78: 307-12. PMID 13704843 DOI: 10.1042/Bj0780307 |
0.717 |
|
1961 |
GETZ GS, BARTLEY W, STIRPE F, NOTTON BM, RENSHAW A. The lipid composition of rat liver The Biochemical Journal. 80: 176-181. PMID 13704842 DOI: 10.1042/Bj0800176 |
0.738 |
|
1959 |
GETZ GS, BARTLEY W. A cardiolipin-like compound in rat liver mitochondria. Nature. 184: 1229-30. PMID 13827682 DOI: 10.1038/1841229A0 |
0.712 |
|
Show low-probability matches. |